
Veenat Imatinib
Targeted therapy oral solid: Veenat Imatinib (400mg) by NexCure Health. GMP-certified for international export.
400mg
Veenat Imatinib 400mg
10 Tablets per strip
NexCure Health
Pricing and availability are confirmed by our team after checking the product, quantity, destination rules, and required documentation.
Bulk quotes, documentation, and shipping options are handled manually after prescription, buyer, and destination checks where applicable.
400mg Veenat Imatinib Tablets IP β a WHO-GMP certified targeted therapy product from NexCure Health. Active composition: Veenat Imatinib 400mg. Pharmacological action: tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity. Clinical use: chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Every batch is quality-verified with HPLC assay, content uniformity, and accelerated stability testing. Supplied with full Certificate of Analysis and export documentation for international pharmaceutical trade.